3Bums A, Rossor M, Hecker J, et al. The effects of donepezil in Alzheimer's disease-results form a multinational trial.Dement Geriatr Cogn Disord, 1999, 10:237.
4Rogers SL, Farlow WR, Doody RS, et al. A 24 week, double-blind placebo-controlled trial of donepezil in patients with Alzheimer' s disease.Neurology, 1998,50: 136.
5Mohs RC, Doody KS, Morris JC, et al. Donepezil preserves activities of daily living in Alzheimer's diseae patients:results form a 1-year placebo-controlled functional survival study.Neurology ,2001, 57:481.
6Winbald B, Engedal K, Soininen H, et al. Donepezil enhances global funedon,congition and activities of daily living compared with placebo in a one-year, double-bind trial in patients with mild to moderate Alzheimer' s disease. Neurology , 2001,57: 489.
7Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet , 1976,2: 1403.
8Bartus RT, Dean RL, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 217 (408) : 417.
9Cummings JL, Back C .The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimor's disease. Am J Geriatric Psychiatry , 1998,6(suppl 1) :s64.
10Schneider IS, Tariot PN. Emerging drugs for Alzheimer's disease mechanism of action and prospects for cognitive enhancing medications. Med Clin Noreh Am, 1994, 78:911.
